表紙
市場調查報告書
商品編碼
1040413

基因生物標誌物的全球市場(2021年∼2027年)

Global Genomic Biomarker Market 2021-2027

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球基因生物標誌物的市場規模,在預測期間內預計以15%以上的年複合成長率發展。

推動該市場成長的主要原因,是癌症、心血管疾病、神經疾病等慢性疾病的盛行率增加,對基因生物標誌物領域的研究、投資增加,醫藥品開發平台的強化的基因生物標誌物服務的利用等。同時,償付相關課題及未開發的市場上特定的市場能力等,有阻礙市場成長的可能性。

本報告提供全球基因生物標誌物市場調查,市場概要,市場成長要素及阻礙因素分析,各適應症、各終端用戶、各地區的分析,競爭情形,再加上主要企業的簡介等全面性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的見解與目前市場趨勢

第3章 競爭情形

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近的開發

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第5章 市場明細

  • 全球基因生物標誌物市場:各適應症
    • 腫瘤學
    • 心血管科
    • 神經科
    • 其他
  • 全球基因生物標誌物市場:各終端用戶
    • 醫院
    • 診斷中心、研究機關

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 其他地區

第7章 企業簡介

  • 23andMe
  • Acobiom SAS
  • Agilent Technologies Inc.
  • Almac Group
  • Banyan Biomarkers, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioMerieux S.A.
  • Celgene Corp.
  • Cofactor Genomics, Inc
  • Destina Genomics Ltd
  • DNAVision SA
  • Eagle Genomics Ltd.
  • Empire Genomics, LLC
  • Enzo Life Sciences, Inc.
  • Epigenomics AG
  • Eurofins Scientific SE
  • Foundation Medicine, Inc.
  • GeneNews Ltd.
  • Genomic Health, Inc.
  • Hologic, Inc.
  • Human Longevity, Inc.
  • Illumina, Inc
  • Insight Genetics Inc.
  • Integragen SA
  • Liquid Genomics, Inc.
  • Luminex Corp.
  • Merck KGaA
  • Myriad Genetics Inc.
  • NeoGenomics Laboratories, Inc.
  • New England Biolabs Inc.
  • Origene Technologies, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Pliant Therapeutics, Inc.
  • Second Genomic Therapeutics
  • Thermo Fisher Scientific Inc.
目錄
Product Code: OMR2023964

Title:
Genomic Biomarker Market
by Disease Indication (Oncology, Cardiology, Neurology, Others), By End-Users (Hospitals, Diagnostic and Research Laboratories) - Global Industry Share, Growth, Competitive Analysis and Forecast Period 2021-2027.

The global genomics biomarker market is projected to exhibit a CAGR of over 15% during the forecast period. Genomic biomarkers is a field of science that aims for the collective characterization and quantification of genes. Genomics additionally includes the sequencing and analysis of genomes using high-throughput DNA sequencing and bioinformatics for assembling and analyzing the function and structure of entire genomes. Major factors contributing to the growth of the market include the increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, neurological disorders, and others. Other driving factors include increasing research and investment in the field of genomic biomarkers and the use of genomic biomarker services for the enhancement of drug development pipelines.

However, some factors are restraining the market growth that includes reimbursement challenges and limited market capabilities in underdeveloped markets. Genomic biomarkers in the development of personalized medicine and rising demand from emerging economies are the factors to create opportunities for the market across the globe.

Segmental Outlook

The global genomic biomarker market is segmented on the basis of disease indication and end-user. By disease indication, the market is segmented into oncology, cardiology, neurology, and others. By end-user, the market is segmented into hospitals and diagnostic and research laboratories.

Among disease indications, oncology contributed a significant share in 2019. The segmental growth is attributed to the high demand for genomic biomarkers in oncology owing to the rise in the prevalence of cancer and an increasing number of research efforts towards genomic biomarkers for cancer detection and understanding therapeutic responses for individual patients.

Regional Outlooks

Geographically, the global genomic biomarker market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. North America contributed a prominent share in the global genomic biomarker market. Factors contributing to the market growth include the presence of well-developed healthcare infrastructure, high healthcare R& D investments, high healthcare expenditure, and others. Europe is another significant market and holds a considerable market share in the global genomic biomarker market.

Market Players Outlook

Some of the key players of the genomic biomarker market include: Agilent Technologies, Inc., Illumina, Inc., Myriad Genetics, Inc., Thermo Fischer Scientific, Inc., Genomic Health Inc., Bio-Rad Laboratories Inc., Second Genomic Therapeutics, and Hologic, Inc. In order to survive in the market, these players adopt different marketing strategies such as a merger and acquisitions, product launch, and geographical expansion. For instance, in 2020, Gilead Sciences, Inc. and Second Genome announced their four-year strategic collaboration to identify biomarkers associated with clinical response and to identify new potential targets and drug candidates for the treatment of IBD (inflammatory bowel disease).

The Report Covers

  • Market value data analysis of 2020 and forecast to 2027
  • Annualized market revenues ($ million) for each market segment
  • Country-wise analysis of major geographical regions
  • Key companies operating in the global Genomic biomarker market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future
  • Analysis of market-entry and market expansion strategies
  • Competitive strategies by identifying 'who-stands-where' in the market

Scope of the Report

This report covers the analysis of the genomic biomarker market on the basis of disease indication, end-user, and region.

Global Genomic Biomarker Market by Disease Indication

  • Oncology
  • Cardiology
  • Neurology
  • Others

Global Genomic Biomarker Market by End-User

  • Hospitals
  • Diagnostic Labs &Research Laboratories

Global Genomic Biomarker Market by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Available Customizations:

With the given market data, customization is available according to the specific requirements of the client. The customization options (not limited to) available for the report are:

  • Further breakdown of a region with respect to a particular country
  • Additional country information
  • Additional segment
  • Analysis and profiles of additional market players

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Genomic Biomarker Market
  • Recovery Scenario of Global Genomic Biomarker Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Genomic Biomarker Market By Disease Indication
    • 5.1.1. Oncology
    • 5.1.2. Cardiology
    • 5.1.3. Neurology
    • 5.1.4. Others
  • 5.2. Global Genomic Biomarker By End-Users
    • 5.2.1. Hospitals
    • 5.2.2. Diagnostic And Research Laboratories

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. 23andMe
  • 7.2. Acobiom SAS
  • 7.3. Agilent Technologies Inc.
  • 7.4. Almac Group
  • 7.5. Banyan Biomarkers, Inc.
  • 7.6. Bio-Rad Laboratories, Inc.
  • 7.7. BioMerieux S.A.
  • 7.8. Celgene Corp.
  • 7.9. Cofactor Genomics, Inc
  • 7.10. Destina Genomics Ltd
  • 7.11. DNAVision SA
  • 7.12. Eagle Genomics Ltd.
  • 7.13. Empire Genomics, LLC
  • 7.14. Enzo Life Sciences, Inc.
  • 7.15. Epigenomics AG
  • 7.16. Eurofins Scientific SE
  • 7.17. Foundation Medicine, Inc.
  • 7.18. GeneNews Ltd.
  • 7.19. Genomic Health, Inc.
  • 7.20. Hologic, Inc.
  • 7.21. Human Longevity, Inc.
  • 7.22. Illumina, Inc
  • 7.23. Insight Genetics Inc.
  • 7.24. Integragen SA
  • 7.25. Liquid Genomics, Inc.
  • 7.26. Luminex Corp.
  • 7.27. Merck KGaA
  • 7.28. Myriad Genetics Inc.
  • 7.29. NeoGenomics Laboratories, Inc.
  • 7.30. New England Biolabs Inc.
  • 7.31. Origene Technologies, Inc.
  • 7.32. Otsuka Pharmaceutical Co., Ltd.
  • 7.33. Pfizer Inc.
  • 7.34. Pliant Therapeutics, Inc.
  • 7.35. Second Genomic Therapeutics
  • 7.36. Thermo Fisher Scientific Inc.

LIST OF TABLES

  • 1. GLOBAL GENOMIC BIOMARKER MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 2. GLOBAL GENOMIC BIOMARKER MARKET BY DISEASE INDICATION, 2020-2027 ($ MILLION)
  • 3. GLOBAL GENOMIC BIOMARKER FOR ONCOLOGY MARKET BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL GENOMIC BIOMARKER FOR CARDIOLOGY MARKET BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL GENOMIC BIOMARKER FOR NEUROLOGY MARKET BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL GENOMIC BIOMARKER FOR OTHER DISEASE INDICATION MARKET BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL GENOMIC BIOMARKER MARKET BY END-USER, 2020-2027 ($ MILLION)
  • 8. GLOBAL GENOMIC BIOMARKER AT HOSPITALS MARKET BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL GENOMIC BIOMARKER AT DIAGNOSTIC AND RESEARCH LABORATORIES MARKET BY REGION,2020-2027 ($ MILLION)
  • 10. GLOBAL GENOMIC BIOMARKER MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 11. NORTH AMERICAN GENOMIC BIOMARKER MARKET RESEARCH AND ANALYSIS BY DISEASE INDICATION, 2020-2027 ($ MILLION)
  • 12. NORTH AMERICAN GENOMIC BIOMARKER MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027 ($ MILLION)
  • 13. NORTH AMERICAN GENOMIC BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 14. EUROPEAN GENOMIC BIOMARKER MARKET RESEARCH AND ANALYSIS BY DISEASE INDICATION, 2020-2027 ($ MILLION)
  • 15. EUROPEAN GENOMIC BIOMARKER MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027 ($ MILLION)
  • 16. EUROPEAN GENOMIC BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 17. ASIA-PACIFIC GENOMIC BIOMARKER MARKET RESEARCH AND ANALYSIS BY DISEASE INDICATION, 2020-2027 ($ MILLION)
  • 18. ASIA-PACIFIC GENOMIC BIOMARKER MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027 ($ MILLION)
  • 19. ASIA-PACIFIC GENOMIC BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 20. REST OF THE WORLD GENOMIC BIOMARKER MARKET RESEARCH AND ANALYSIS BY DISEASE INDICATION, 2020-2027 ($ MILLION)
  • 21. REST OF THE WORLD GENOMIC BIOMARKER MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL GENOMIC BIOMARKER MARKET SHARE BY DISEASE INDICATION, 2020 VS 2027 (%)
  • 2. GLOBAL GENOMIC BIOMARKER MARKET SHARE BY END-USERS, 2020 VS 2027 (%)
  • 3. GLOBAL GENOMIC BIOMARKER MARKET SHARE BY GEOGRAPHY, 2020 VS 2027, (%)
  • 4. GLOBAL GENOMIC BIOMARKER FOR ONCOLOGY MARKET BY REGION, 2020 VS 2027 (%)
  • 5. GLOBAL GENOMIC BIOMARKER FOR CARDIOLOGY MARKET BY REGION, 2020 VS 2027 (%)
  • 6. GLOBAL GENOMIC BIOMARKER FOR NEUROLOGY MARKET BY REGION, 2020 VS 2027 (%)
  • 7. GLOBAL GENOMIC BIOMARKER FOR OTHER DISEASE INDICATION MARKET BY REGION, 2020 VS 2027 (%)
  • 8. GLOBAL GENOMIC BIOMARKER AT HOSPITALS MARKET BY REGION, 2020 VS 2027 (%)
  • 9. GLOBAL GENOMIC BIOMARKER AT DIAGNOSTIC AND RESEARCH LABORATORIES MARKET BY REGION, 2020 VS 2027 (%)
  • 10. US GENOMIC BIOMARKER MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. CANADA MARKET GENOMIC BIOMARKER MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. UK GENOMIC BIOMARKER MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. GERMANY GENOMIC BIOMARKER MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. SPAIN GENOMIC BIOMARKER MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. FRANCE GENOMIC BIOMARKER MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. ITALY GENOMIC BIOMARKER MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. REST OF EUROPE GENOMIC BIOMARKER MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. INDIA GENOMIC BIOMARKER MARKET SIZE, 2020-2027 ($ MILLION)
  • 19. CHINA GENOMIC BIOMARKER MARKET SIZE, 2020-2027 ($ MILLION)
  • 20. JAPAN GENOMIC BIOMARKER MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. REST OF ASIA-PACIFIC GENOMIC BIOMARKER MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. REST OF WORLD GENOMIC BIOMARKER MARKET SIZE, 2020-2027 ($ MILLION)